FMTX - Forma Therapeutics names industry veteran John Bishop as chief technology officer

Forma Therapeutics Holdings (FMTX) announces the appointment of industry veteran John Bishop as senior vice president and chief technology officer.In this role, Bishop will lead chemistry, manufacturing and control ((CMC))-related functions and quality, encompassing Forma’s early pipeline through commercial product.Bishop’s background includes extensive expertise with CMC development in oncology and hematology.Prior to joining Forma, He served as senior vice president of pharmaceutical sciences at Epizyme.Shares of the company were up nearly 5% premarket.

For further details see:

Forma Therapeutics names industry veteran John Bishop as chief technology officer